30,593 Baxter International Inc. $BAX Shares Bought by Sterling Capital Management LLC

Sterling Capital Management LLC grew its stake in Baxter International Inc. (NYSE:BAX) by 197.9% during the third quarter, HoldingsChannel.com reports. The firm owned 46,051 shares of the medical instruments supplier’s stock after purchasing an additional 30,593 shares during the period. Sterling Capital Management LLC’s holdings in Baxter International were worth $1,105,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the stock. CX Institutional grew its stake in Baxter International by 2.3% in the third quarter. CX Institutional now owns 19,858 shares of the medical instruments supplier’s stock worth $477,000 after purchasing an additional 448 shares in the last quarter. Baird Financial Group Inc. raised its stake in Baxter International by 1.1% during the second quarter. Baird Financial Group Inc. now owns 44,722 shares of the medical instruments supplier’s stock valued at $953,000 after buying an additional 476 shares in the last quarter. CWA Asset Management Group LLC raised its stake in Baxter International by 5.0% during the third quarter. CWA Asset Management Group LLC now owns 12,617 shares of the medical instruments supplier’s stock valued at $303,000 after buying an additional 599 shares in the last quarter. Empirical Finance LLC raised its stake in Baxter International by 3.5% during the second quarter. Empirical Finance LLC now owns 18,170 shares of the medical instruments supplier’s stock valued at $387,000 after buying an additional 608 shares in the last quarter. Finally, CYBER HORNET ETFs LLC lifted its holdings in Baxter International by 52.4% during the 2nd quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock worth $46,000 after buying an additional 740 shares during the last quarter. Institutional investors and hedge funds own 90.19% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. TD Cowen lifted their target price on Baxter International from $20.00 to $24.00 and gave the stock a “hold” rating in a research report on Monday, July 27th. Citigroup lowered their price target on Baxter International from $28.00 to $27.00 and set a “neutral” rating for the company in a report on Monday, October 5th. Stifel Nicolaus upped their price target on Baxter International from $19.00 to $24.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. Wells Fargo & Company raised their price objective on Baxter International from $19.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Finally, Barclays started coverage on shares of Baxter International in a report on Wednesday, October 7th. They issued an “underweight” rating and a $20.00 price objective for the company. One equities research analyst has rated the stock with a Buy rating, ten have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, Baxter International currently has an average rating of “Reduce” and an average target price of $21.73.

Baxter International Price Performance

Shares of NYSE:BAX opened at $25.30 on Tuesday. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 1.39. Baxter International Inc. has a fifty-two week low of $15.73 and a fifty-two week high of $30.00. The firm has a 50-day simple moving average of $24.77 and a 200 day simple moving average of $21.27. The company has a market cap of $13.08 billion, a PE ratio of -12.22, a P/E/G ratio of 3.83 and a beta of 0.65.

Baxter International (NYSE:BAX) last released its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.19. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. The firm had revenue of $2.96 billion for the quarter, compared to analyst estimates of $2.80 billion. During the same quarter in the prior year, the business earned $0.59 earnings per share. Baxter International’s quarterly revenue was up 5.3% on a year-over-year basis. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. On average, sell-side analysts anticipate that Baxter International Inc. will post 2.04 EPS for the current year.

Baxter International Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Friday, August 28th were given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Friday, August 28th. Baxter International’s dividend payout ratio is presently -1.93%.

About Baxter International

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.